Silent cerebral infarct after cardiac catheterization as detected by diffusion weighted Magnetic Resonance Imaging: a randomized comparison of radial and femoral arterial approaches
Trials volume 8, Article number: 15 (2007)
Background and objective
Cerebral microembolism detected by transcranial Doppler (TCD) occurs systematically during cardiac catheterization, but its clinical relevance, remains unknown. Studies suggest that asymptomatic embolic cerebral infarction detectable by diffusion-weighted (DW) MRI might exist after percutaneous cardiac interventions with a frequency as high as 15 to 22% of cases. We have set up, for the first time, a prospective multicenter trial to assess the rate of silent cerebral infarction after cardiac catheterization and to compare the impact of the arterial access site, comparing radial and femoral access, on this phenomenon.
This prospective study will be performed in patients with severe aortic valve stenosis. To assess the occurrence of cerebral infarction, all patients will undergo cerebral DW-MRI and neurological assessment within 24 hours before, and 48 hours after cardiac catheterization and retrograde catheterization of the aortic valve. Randomization for the access site will be performed before coronary angiography. A subgroup will be monitored by transcranial power M-mode Doppler during cardiac catheterization to observe cerebral blood flow and track emboli. Neuropsychological tests will also be recorded in a subgroup of patients before and after the interventional procedures to assess the impact of silent brain injury on potential cognitive decline. The primary end-point of the study is a direct comparison of ischemic cerebral lesions as detected by serial cerebral DW-MRI between patients explored by radial access and patients explored by femoral access. Secondary end-points include comparison of neuropsychological test performance and number of microembolism signals observed in the two groups.
Using serial DW-MRI, silent cerebral infarction rate will be defined and the potential influence of vascular access site will be evaluated. Silent cerebral infarction might be a major concern during cardiac catheterization and its potential relationship to cognitive decline needs to be assessed.
The SCIPION study is registered through National Institutes of Health-sponsored clinical trials registry and has been assigned the Identifier: NCT 00329979.
Acute cerebral infarction following cardiac catheterization is rare [1–3], but silent brain injury could occur at an unexpectedly high rate [3–6] as detected by diffusion-weighted (DW) magnetic resonance imaging (MRI). Indeed the high sensitivity of DW-MRI suggests that this technique could allow an improved estimate of cerebral ischemic events associated with cardiovascular catheterization procedures and could be used therefore as a surrogate endpoint for risk assessment of stroke . The use of transcranial Doppler (TCD) sonography allows the recording of microemboli entering the middle cerebral artery during various endovascular interventions, including cardiac catheterization [8, 9]. In the case of coronary bypass surgery, evidence indicates that microembolism might be related to cognitive impairment, based on the results of neuropsychological testing . During cardiac catheterization, cerebral microembolism as detected by TCD has frequently been observed, but whether it is clinically relevant remains unknown [8, 9]. However, recent studies mentioned above, have suggested that some of these microemboli could be related to silent cerebral embolisms responsible for acute ischemic brain injury, as documented by DW-MRI [3–6]. Furthermore there is increasing evidence that cumulative burden of ischemic brain injury causes neuropsychological deficits or aggravates vascular dementia . Thus DW-MRI emerges as a valuable diagnostic method for the monitoring of periprocedural ischemic events in the brain and could be considered as a surrogate parameter for optimising diagnostic and therapeutic vascular interventions.
In the present trial two vascular access sites (trans-radial approach [TRA] and trans-femoral approach [TFA]) routinely used for cardiac catheterization and percutaneous cardiovascular interevention (PCI) will be compared for the risk of silent brain injury occurrence. Indeed TRA is associated with fewer local complications and it has been suggested that in particular right TRA, which avoids crossing the aortic arch could reduce the risk of mobilization of atherosclerotic plaque, present particularly within the aortic arch as documented previously by several authors [12–14]. However this risk of brain injury in relation to vascular access site remains largely debatable. Using DW-MRI as a surrogate parameter for brain injury assessment we propose a prospective evaluation of the occurrence of silent brain lesions in patients randomized either to TRA or TFA.
Design and methods
Prospective multicenter randomized trial (4 centers currently involved: 2 in France, 1 in Italy and 1 in Austria).
Assessment in a prospective multicenter trial of the rate of silent brain injury after cardiac catheterization
Comparison of the TRA and the TFA on the occurrence of new cerebral lesions as detected by DW-MRI
Implication of silent brain infarction(s) on potential cognitive impairment
(i) Primary end-point
Number of patients observed with new cerebral lesions either symptomatic or not after cardiac catheterization as detected by DW-MRI in each group (comparison of radial and femoral access).
(ii) Secondary end-points
Impact of potential silent cerebral infarction on cognitive impairement.
Number of microembolism signals observed at TCD between the two groups.
Patients with severe aortic stenosis scheduled for cardiac catheterization because of aortic valve stenosis to assess coronary artery tree and aortic valve disease before surgery will be prospectively and consecutively invited to participate in the study. After informed consent is obtained the patient will be included. Exclusion criteria will be a contraindication to MRI or inability to give written informed consent.
All patients will be examined clinically by a senior physician and assessed for any history of previous cerebral embolism. Transthoracic echocardiography, 12-lead surface electrocardiogram, and coronary angiography will be performed for all patients. Cardiac catheterizations will be undertaken by expert interventional cardiologists using a standard Seldinger technique using 5 French (F) catheters either by TRA or TFA according to randomization assignment. Sheaths will be removed immediately after the procedure in all patients. Unfractionated heparin (50 iu/kg) will be given intravenously to all patients at the beginning of the procedure. Retrograde catheterization of aortic valve will be attempted in a right oblique projection using a long exchange guidewire (0.035 inch, 260 cm length to ensure exchange of the pigtail catheter) using a left amplatz 1 catheter or a right Judkins catheter . During attempts to cross the aortic valve, the wire will be regularly withdrawn and cleaned and the catheter flushed every 2 minutes according to Grossman's recommendations . When the pigtail catheter is placed in the left ventricle, the wire will be withdrawn and the catheter vigorously aspirated and pressure measurements performed. After left ventriculography, the catheter will be rapidly withdrawn from the left ventricle into the ascending aorta with simultaneous pressure measurements. Maximum and mean pressure gradients will be established. The duration of the whole procedure and fluoroscopic time in all patients will also be recorded.
Magnetic resonance imaging
MRI will be done within 24 hours before, and 48 hours after, cardiac catheterization. MRI will be performed with a 1.5 Tesla system. The imaging protocol will include a DW single-shot spin echo echoplanar sequence acquired in the Anterior Commissure-Posterior Commissure plane with 24 contiguous sections (diffusion gradient b values of 0 and 1000 s/mm2, repetition time TR 6000 ms, echo time TE 120 ms, slice thickness 6 mm with no gap, matrix of 128 × 128 pixels, and field of view of 240 mm); fluid attenuated inversion recovery (FLAIR; TR/TE 10000/160 ms, TI 2200 ms); and T2-weighted turbo spin echo sequences (TR/TE 3500/94 ms). For DW-MRI, the diffusion gradients will be successively and separately applied in three orthogonal directions for a total acquisition time of 24 seconds. Trace images will then be generated and apparent diffusion coefficient (ADC) maps calculated with a dedicated software tool available on all recent MRI machines. The image analysis will be performed independently by two experienced neuroradiologists who will be blinded to the clinical data and will be unaware of the technical aspects of the angiographic cardiac procedure. For analysis of DW-MRI, the neuroradiologists will be asked to determine the presence, size, number, and vascular distribution of any focal diffusion abnormalities (bright lesions) in a pattern consistent with embolic lesions. Typical positive DW-MRI showing bright lesions (cerebral infarct) in asymptomatic patients are shown in Figures 1 and 2.
Transcranial Doppler studies for this work will be performed in a subgroup of patients with the TCD power M-mode Doppler (PMD) 100 (Spencer Technologies, Seattle, WA), which calculates a PMD image concurrently with a single-gate spectrogram as previously described with a threshold of 2 MHz . Bilateral power M-mode TCD will be recorded during cardiac catheterization through the temporal bones of patients with an automatic detection of microemboli. The PMD image shows depth from the probe on the vertical axis, time on the horizontal axis, and power of the Doppler shift signal at specific depths as color intensity. Simultaneously, the direction of blood flow is derived from the positive or negative mean value of the Doppler shift signal at the particular depth. This mean velocity information is used in the PMD image as red, depicting flow toward the probe, and blue as flow away from the probe.
Microembolic signals present a unique signature or "track" in the PMD image, which defines them as representing emboli. These potential embolic tracks in the middle cerebral arteries (MCA, red) and the anterior cerebral arteries (ACA, blue) PMD images have simultaneous spectrogram signatures. However, the spectrogram signatures are restricted to the point in time that the PMD embolic track crosses the gate depth associated with the spectrogram (yellow line). The potential MCA microembolus, which moves toward the probe as time progresses, will have a positively sloped track within the image consistent with its movement direction. The ACA microembolus, which moves away from the probe as time progresses, will have a negatively sloped track within the image. High-power/high-intensity, transient unidirectional signals correspond to the definition of microembolic signature approved by the Consensus Committee of the 9th Cerebrovascular Hemodynamics Symposium . Typical recordings of microembolic signals during cardiac catheterization are shown in Figure 3 and 4.
Patients will undergo neuropsychological assessment within 24 hours before, and 48 hours after, cardiac catheterization. All patients with documented cerebral infarction at DW-MRI will be asked to come back for a new neuropsychological assessment at 1 year follow-up.
The aim of the cognitive testing is to provide clinical evidence of potential cerebral damage after cardiac catheterization and to quantify this potential cognitive decline allowing comparison of two groups of patients explored either by radial or femoral approaches. The tests must be sensitive enough to detect potential post-procedure cognitive decline and also able to explore different brain areas. Most of the neuropsychological tests that will be administered have been reported to be sensitive to change after CABG or PCI procedures  and will include: Digit Span Forwards and Backwards, Trail making test A and B, Wechsler Memory Scale visual reproduction test, Rey-Osterrieth's figure test, Grober-Buschckle's test, Rey Auditory Verbal Learning Test, Verbal fluency test, and Confrontation naming test.
Baseline characteristics of the study population will be presented as counts and percents for categorical variables and as mean ± SD for continuous variables. Kappa statistic will be calculated to determine interobserver agreement. The number of lesions in our population of patients recruited will be estimated by the adjusted Wald interval at 95% in accordance with the method recommended by Agresti & Coull . With small sample sizes, as recommended we will use the mid-point of the adjusted Wald interval instead of the observed proportion . The statistical analyses will be performed using SPSS 10.0.7 software (Chicago, IL, USA). The compound score for global cognitive function will be constructed by calculating the average of the z scores for all the above tests. Cognitive decline will be calculated by subtracting the z scores for memory performance, psychomotor speed, and global cognitive function at follow-up from the z scores at base line. All analyses will be adjusted for age, sex, and level of education, as well as the interval between the two sets of neuropsychological tests.
Sample size calculation
Based on a pilot study  we think that radial approach will be associated with a median rate of 5.9% [0.01–12.5;95%CI] of new lesions as detected by cerebral DW-MRI. In patients with aortic stenosis explored by femoral approach we expect a 23% [15–31;95%CI] rate of similar events . With randomization 1:1 an alpha risk of 5% and beta risk of 20% we anticipate a sample size population of 152 patients needed to demonstrate that radial approach could be associated with better outcome concerning the occurrence of silent cerebral infarctions (76 patients in each arm of the study).
After informed consent, eligible patients are randomized 1:1 to a strategy of radial or femoral access. Randomization will be performed at the catheterization laboratory before coronary angiography, by means of randomization list (sealed envelopes) prepared by blocks of 10 patients.
According to previous studies, the rate of stroke after cardiac catheterization ranges from 0.10 % to 0.40 % . However, these studies on the risk of stroke after cardiac catheterization have taken only manifest new neurological deficits as complications. Clinically unapparent damage potentially caused by microscopic air embolism or silent thromboembolism, had not been taken into account. With the advent of DW-MRI, which is very sensitive in detecting acute ischemic lesions within hours after onset , it has been shown that asymptomatic embolic events are far more frequent than the apparent neurological complication rate [3–6]. It seems that only the length of the procedure or the procedural fluoroscopy time can be independently associated with the risk of cerebral infarction in these studies. These two parameters are related to the overall influence of the catheter manipulation including additional periods of time while the catheter acts as a embolic source because it may lead to thrombus formation or affect the vessel wall during manipulation or placement in the patient's vascular system. It has also been suggested that silent acute brain injury can be increased using trans-radial access  but this has not been demonstrated.
Because all cardiac catheterizations are associated with microembolism as detected by TCD it has been suggested that most of these microembolism might be microbubbles and are therefore likely to be benign. However some recent publications, mentioned above, raise the possibility that some microparticles embolized during heart catheterization could be responsible for acute brain injuries. In fact, the most likely sources of embolic material are catheters and guidewires that dislodge atheromatous material from the aorta . Visible aortic debris may be seen upon withdrawal of catheters during PCI cases . Patients with a large atherosclerotic burden in the aorta as documented by transesophageal echocardiography, such as those with advanced coronary artery disease, have an increased risk of cardiac catheterization-induced stroke . It has been shown that patients with cardiac catheterization-induced stroke often have multiple acute lesions on DW-MRI (often tiny, cortical, and in different vascular territories), distinct from the occasionally symptomatic lesion, and consistent with a shower of embolic material.
Silent cerebral infarction might be a major concern during cardiac catheterization and its potential relationship with cognitive decline needs to be assessed prospectively in a multicenter study. In the SCIPION trial we will use serial DW-MRI to assess the rate of silent cerebral infarction after cardiac catheterization and we will compare the impact of the arterial access site (radial or femoral) on this emerging phenomenon.
Segal AZ, Abernethy WB, Placios IF, BeLue R, Rordorf G: Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology. 2001, 56: 975-977.
Wong SC, Minutello R, Hong MK: Neurological complications following percutaneous coronary interventions (A report from the 2000–2001 new York state angioplasty registry). Am J Cardiol. 2005, 96: 1248-1250. 10.1016/j.amjcard.2005.06.065.
Omran H, Schmidt H, Hackenbroch M, Illien S, Bernhardt P, von der Recke G, Fimmers R, Flacke S, Layer G, Pohl C, Luderitz B, Schild H, Sommer T: Silent and apparent cerebral embolism after retrograde catheterization of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet. 2003, 361: 1241-1246. 10.1016/S0140-6736(03)12978-9.
Busing KA, Schulte-Sasse C, Flucher S, Suelbeck T, Haase KK, Neff W, Hirsch JG, Borggrefe M, Duber C: Cerebral infarction incidence and risk factors after diagnostic and interventional cardiac catheterization-prospective evaluation at diffusion-weighted MR imaging. Radiology. 2005, 235: 177-183. 10.1148/radiol.2351040117.
Lund C, Nes RB, Ungelstadt TP, Due-Tonnessen P, Andersen R, Hol PK, Brucher R, Russell D: Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J. 2005, 26: 1269-75. 10.1093/eurheartj/ehi148.
Hamon M, Gomes S, Oppenheim C, Morello R, Sabatier R, Lognoné T, Grolier G, Courtheoux P, Hamon M: Cerebral microembolism during cardiac catheterization and risk of acute brain injury. A prospective diffusion weighted magnetic resonance imaging study. stroke. 2006, 37: 2035-2038. 10.1161/01.STR.0000231641.55843.49.
Britt PM, Heiserman JE, Snider RM, Schill HA, Bird CR, Wallace RC: Incidence of postangiographic abnormalities revealed by diffusion-weighted MR imaging. Am J Neuroradiol. 2000, 21: 55-59.
Leclercq F, Kassnasrallah S, Cesari JB, Blard JM, Macia JC, Messner-Pellenc P, Mariottini CJ, Grolleau-Raoux R: Transcranial Doppler detection of cerebral microemboli during left heart catheterization. Cerebrovasc Dis. 2001, 12: 59-65. 10.1159/000047682.
Bladin CF, Bingham L, Grigg L, Yapanis AG, Gerraty R, Davis SM: Transcranial Doppler detection of microemboli during percutaneous transluminal coronary angioplasty. Stroke. 1998, 29: 2367-70.
Lund C, Sundet K, Tennoe B, Hol PK, Rein KA, Fosse E, Russell D: Cerebral ischemic injury and cognitive impairment after off-pump and on-pump coronary artery bypass grafting surgery. Ann Thorac Surg. 2005, 80: 2126-31. 10.1016/j.athoracsur.2005.06.012.
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003, 348: 1215-22. 10.1056/NEJMoa022066.
Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S: Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000, 139: 329-36. 10.1067/mhj.2000.101225.
Khoury Z, Gottlieb S, Stern S, Keren A: Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. Am J Cardiol. 1997, 79: 23-7. 10.1016/S0002-9149(96)00670-4.
Karalis DG, Quinn V, Victor MF, Ross JJ, Polansky M, Spratt KA, Chandrasekaran K: Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J. 1996, 131: 1149-55. 10.1016/S0002-8703(96)90090-3.
Meine TJ, Harrison JK: Should we cross the valve: The risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. Am Heart J. 2004, 148: 41-42. 10.1016/j.ahj.2004.05.031.
Grossman W, Baim DS: Cardiac catheterization, angiography and intervention. 1991, Lea and Febiger, 4
Moehring MA, Spencer MP: Power M-mode Doppler for observing cerebral blood flow and tracking emboli. Ultrasound in Med and Biol. 2002, 49-57. 10.1016/S0301-5629(01)00486-0.
Basic Identification Criteria of Doppler Microembolic Signals. Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. Stroke. 1995, 26: 1123-
Agresti A, Coull BA: Approximate is better than exact for interval estimation of binomial proportions. The American Statistician. 1998, 52: 119-126. 10.2307/2685469.
Wahrborg P, Booth JE, Clayton T, Nugara F, Pepper J, Weintraub WS, Sigwart U, Stables RH: Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial. Circulation. 2004, 110: 3411-7. 10.1161/01.CIR.0000148366.80443.2B.
Sauro J, Lewis JR: Estimating Completion Rates from Small Samples using Binomial Confidence Intervals: Comparisons and Recommendations. Proceedings of the Human Factors and Ergonomics Society Annual Meeting (HFES 2005) Orlando, FL.
Brown DL, Topol EJ: Stroke complicating percutaneous coronary revascularization. Am J Cardiol. 1993, 72: 1207-1209. 10.1016/0002-9149(93)90998-R.
Biondi A, Oppenheim C, Vivas E, Casasco A, Lalam T, Sourour N, Le Jean L, Dormont D, Marsault C: Cerebral aneurysms treated by Guglielmi detachable coils : Evaluation with diffusion-weighted MR Imaging. Am J Neuroradiol. 2000, 21: 957-963.
Braekken SK, Endresen K, Russel D, Brucher R, Kjekshus J: Influence of guidewire and catheter type on the frequency of cerebral microembolic signals during left heart catheterization. Am J Cardiol. 1998, 82: 632-637. 10.1016/S0002-9149(98)00407-X.
Keeley EC, Grines CL: Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998, 32: 1861-5. 10.1016/S0735-1097(98)00497-5.
Principal Investigator: Martial Hamon, MD, Department of Cardiology University Hospital of Caen, France.
Michèle Hamon, MD, Department of Radiology University Hospital of Caen, Normandy, France; Martial Hamon, MD, Department of Cardiology University Hospital of Caen, Normandy, France; Fausto Viader, MD, Department of Neurology University Hospital of Caen, Normandy, France.
Francesco Burzotta, MD, PhD, Institute of Cardiology and Luigi Natale, Institute of Radiology, Catholic University of the Sacred Heart, Rome, Italy; Catherine Oppenheim, MD, PhD, Saint Anne Hospital, Paris Descartes University, Paris, France; Rémi Morello, MD, MPH, Department of Statistics University Hospital of Caen, Normandy, France;Christian Pristipino, MD, San Filippo Neri Hospital, Via Borgorose 5, 00189 Rome, Italy.
Gilles Grollier, MD, Rémi Sabatier, MD, Thérèse Lognoné, MD, John Shayne, MD, Karam Souibri, MD, Benoit Valette, MD, Sophie Gomes, MD, Eric saloux, MD, Martial Hamon, MD, Department of Cardiology University Hospital of Caen, Normandy, France. Fausto Viader, MD, Arnaud Duretete, MD, PhD, Department of Neurology University Hospital of Caen, Normandy, France. Michèle Hamon, MD, Patrick Courtheoux, MD, Department of Radiology University Hospital of Caen, Normandy, France. Francesco Burzotta, MD, PhD, Carlo Trani, MD, Giovanni Schiavoni, Institute of Cardiology and Luigi Natale, Institute of Radiology, Catholic University of the Sacred Heart, Rome, Italy. Thomas Brunner, MD, Vienna, Austria. Janusz Lipiecki, MD, Clermont-Ferrand, France.
The author(s) declare that they have no competing interests.
All authors have read and approved the final manuscript.
About this article
Cite this article
Hamon, M., Burzotta, F., Oppenheim, C. et al. Silent cerebral infarct after cardiac catheterization as detected by diffusion weighted Magnetic Resonance Imaging: a randomized comparison of radial and femoral arterial approaches. Trials 8, 15 (2007). https://doi.org/10.1186/1745-6215-8-15